As the weather warms up, people start filling the courts, fields, greens and trails looking to get back in shape and practice their game. However, this also means there are plenty of opportunities for cuts and bruises, ankle sprains, muscle strains, and knee injuries, to name a few.

Quality of care varies greatly for the treatment of men with early-stage prostate cancer by region of the country and category of health care facility, suggesting the potential for improved patient outcomes with more standard treatment protocols, according to a new study that was published in the Aug. 1 issue of the Journal of Clinical Oncology (2008: Vol. 26, Issue 22).

NewYork-Presbyterian Hospital/Weill Cornell Medical Center announced today the nine-month interim results of an ongoing Phase II clinical trial of GAMMAGARD Intravenous Immunoglobulin (IGIV) for Alzheimer's disease at the Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) in Chicago.

Parents should not worry that proposed changes to the medical criteria redefining a diagnosis of autism will leave their children excluded and deemed ineligible for psychiatric and medical care, says a team of researchers led by psychologists at Weill Cornell Medical College.

Blood pressure medications are currently failing millions of Americans, who continue to battle hypertension and remain at increased risk for heart attack and stroke.

Holiday dinners are filled with heaping dishes of comfort foods, fattening favorites and savory treats. It is no wonder these meals often leave us feeling stuffed with guilt and holiday remorse.

Researchers at Weill Cornell Medical College were awarded a $6.5 million grant from the National Heart, Lung, and Blood Institute for a five-year investigation into metabolic changes occurring within airway epithelial cells in the lungs of chronic obstructive pulmonary disease (COPD) patients caused by cigarette smoking. In addition, researchers aim to identify which cigarette smokers are at highest risk of developing COPD as well as novel biomarkers to assist in the development of new therapeutic treatments for the disease.

The Ronald O. Perelman Heart Institute at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is hosting a graduation ceremony for its first class of Faith-Based Ambassadors of Health. After participating in a 12-week training course this group of pastors and ministers from churches and ministries in Brooklyn, Queens, Harlem and Staten Island are now prepared to educate their congregations about reducing the risk factors for heart disease.